ClinicalTrialsFinder
RecruitingNot ApplicableNCT07070401

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

Sponsor

Community Medical Center, Toms River, NJ

Enrollment

92 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Renal ColicKidney Stones, Urolithiasis, Hypocitraturia

Summary

Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients

Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Patient self-reported history of nephrolithiasis
  • Subjective history suggesting that current presentation is similar to past presentations of nephrolithiasis (character, quality, location, intensity of pain; previous surgical intervention or lithotripsy)
  • Patients with self-reported moderate to severe pain on the visual pain scale determined as greater than 5/10
  • Normal vital signs (afebrile)
  • Agreeable to informed consent as dictated by IRB and local practice
  • No contraindications to standard therapy (ie fluids, NSAIDs, opioids, etc.)
  • Compliance with the virtual reality treatment
  • Keeps the headset on for the duration of the experience
  • Understands the instructions

Exclusion Criteria11

  • Age \< 18 years
  • Pregnant
  • Individuals with chronic pain conditions such as fibromyalgia (chronic pain may confound results, as patients may have higher than baseline pain levels affecting their response to medications)
  • Individuals with severe anxiety or claustrophobia
  • Individuals with severe motion sickness or previous episodes of motion sickness due to VR (those who may not react well to the VR experience)
  • Individuals with GFR\<60 or previous documented diagnosis of CKD as they may not be suitable candidate for traditional analgesia
  • Individuals with previous opioid dependence
  • Requirement of immediate surgery (obstructing calculi with concomitant urinary tract infection)
  • Patients with diagnoses meeting admission criteria (sepsis, MI)
  • Audio/visual impairment (unable to appreciate stimuli provided by the headset)
  • Patients administered opiates as the first line pain control medication will not be included in final data collection, as opioid administration may result in difficulty consenting and understanding the study protocol / design

Interventions

DEVICECommercial AR/VR Headset with Calming App

Commercial AR/VR Headset with Calming App in addition to Pharmacologic Standard of Care

OTHERPharmacologic Standard of Care Alone

Pharmacologic Standard of Care Alone

Locations(1)

Rutgers Robert Wood Johnson Barnabas Health Community Medical Center

Toms River, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07070401